CADTH | Evidence Driven
CADTH | Evidence Driven

Transcutaneous Bilirubin Measurements in Newborns: Clinical and Cost-Effectiveness, and Guidelines

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1164-000

Question


  1. What is the clinical effectiveness and diagnostic accuracy of transcutaneous bilirubin measurements in newborns?

  2. What is the cost-effectiveness of transcutaneous bilirubin measurements in newborns compared with serum bilirubin measurements?

  3. What are the evidence-based guidelines regarding transcutaneous bilirubin measurements in newborns?


Key Message

One health technology assessment report, one systematic review with meta-analysis, one randomized controlled trial, 21 non-randomized studies, and one economic evaluation were identified regarding the clinical effectiveness, diagnostic accuracy, or cost-effectiveness of transcutaneous bilirubin measurements in well newborns. Additionally, three evidence-based guidelines were identified.


Files

Transcutaneous Bilirubin Measurements in Newborns: Clinical and Cost-Effectiveness, and Guidelines Rapid Response November 21, 2017 View PDF

Related Content

Last Updated : November 21, 2017